Back to Speakers
Kathryn Vaughn

Kathryn Vaughn

Market Access DirectorColoplast

Kathryn Vaughn, PT, DPT is the Director of Market Access at Coloplast, where she leads a team focused on protecting and improving access to innovative products for individualas with intimate healthcare needs. 

Mon Mar 022:15 PM – 3:15 PM126 A-C

MC02: From Code Activation to Access: Overcoming Delays in Payor Adoption

Overview of the new intermittent catheter (IC) HCPCS codes and the implications of them for suppliers, payors, and patients; explain implementation la…Overview of the new intermittent catheter (IC) HCPCS codes and the implications of them for suppliers, payors, and patients; explain implementation lag and factors driving the lag; highlight the real-world impact we have experienced when payors do no…Overview of the new intermittent catheter (IC) HCPCS codes and the implications of them for suppliers, payors, and patients; explain implementation lag and factors driving the lag; highlight the real-world impact we have experienced when payors do not implement on time, proactive strategies and tools for manufacturers and suppliers to consider to minimize disruption. Session will include a brief lecture followed by a panel discussion with time fo…Overview of the new intermittent catheter (IC) HCPCS codes and the implications of them for suppliers, payors, and patients; explain implementation lag and factors driving the lag; highlight the real-world impact we have experienced when payors do not implement on time, proactive strategies and tools for manufacturers and suppliers to consider to minimize disruption. Session will include a brief lecture followed by a panel discussion with time for audience Q&As; panel representation will include panelists from Coloplast, an IC manufacturer, and Comfort Medical, an IC supplier. Show MoreClick the title to see all detailsShow More

Panel (3 or more speakers; 90 min)Session TypeManaged CareSession Track
Kathryn Vaughn
Joel Segar
Jon Hanczaryk
Kathryn Vaughn
Kathryn VaughnMarket Access Director, Coloplast
Joel Segar
Joel SegarDirector, Regulatory Affairs & Payer Relations, Comfort Medical
Jon Hanczaryk
Jon HanczarykSenior Manager of Reimbursement, Payors & Evidence Team, Coloplast
Kathryn Vaughn
Kathryn VaughnMarket Access Director, Coloplast
Joel Segar
Joel SegarDirector, Regulatory Affairs & Payer Relations, Comfort Medical
Jon Hanczaryk
Jon HanczarykSenior Manager of Reimbursement, Payors & Evidence Team, Coloplast
Allow Registration:No
Capacity Unlimited:Yes
Do you feel as though there is a topic missing?:No
If yes, who would you recommend as your fellow panelist?:Joel Segar from Comfort Medical
Please include five learning objectives::1) Understand structure/ purpose of new IC codes; 2) Analyze implications of coding changes across stakeholders; 3) Identify key drivers and impact of code implementation lag; 4) apply real-world lessons; 5) develop strategies to navigate code transitions